Table 2 (a) Breakdown, by site, of clinical characteristics of adult patients with obsessive–compulsive disorder (OCD) in the ENIGMA OCD Working Group samples; (b) Breakdown, by site, of clinical characteristics of pediatric patients with obsessive–compulsive disorder (OCD) in the ENIGMA OCD Working Group samples.
Site | OCD/HC (N) | Medicated (%) | Age of onset | Duration of illness | YBOCS score | Lifetime anxiety (%) | Lifetime depression % |
|---|---|---|---|---|---|---|---|
(a) | |||||||
Amsterdam | 38/34 | 0 | 15.1 ± 6.8 | 23.7 ± 12.8 | 21.3 ± 6.1 | 42.1 | 47.4 |
Bangalore | 158/131 | 39.9 | 22.3 ± 7.7 | 7.2 ± 5.2 | 25.5 ± 6.5 | 8.9 | 7 |
Capetown | 22/23 | 40.9 | 13.2 ± 5.7 | 17.2 ± 11.5 | 23 ± 4.2 | 0 | 0 |
Kyoto | 35/41 | 0 | 25.2 ± 9 | 7.7 ± 6.2 | 21.9 ± 6.6 | 8.6 | 0 |
Milan | 63/65 | 60.3 | 15.6 ± 6.2 | 18.9 ± 11.6 | 31.4 ± 5.2 | 1.6 | 7.9 |
Mount Sinai | 16/18 | 81.3 | 12.4 ± 5.7 | 15.1 ± 6.7 | 19.9 ± 5.9 | 50 | 18.8 |
Munich | 73/60 | 60.3 | 17.6 ± 6.7 | 13.5 ± 10.3 | 20.8 ± 6.2 | 8.2 | 23.3 |
Rome | 77/111 | 94.8 | 16.8 ± 8 | 17.3 ± 12.8 | 23.2 ± 9.3 | 10.4 | 9.1 |
Sao Paulo | 37/30 | 43.2 | 12.8 ± 5.9 | 26.3 ± 13.5 | 29.2 ± 6.2 | 73 | 83.8 |
Shangai | 83/45 | 0 | 24 ± 9.9 | 6 ± 5.9 | 26.2 ± 4.7 | 0 | 0 |
Seoul | 98/87 | 13.3 | 19.1 ± 7.2 | 6.2 ± 7 | 25.8 ± 6.9 | 1 | 2 |
(b) | |||||||
|---|---|---|---|---|---|---|---|
Bangalore | 13/13 | 85 | 12.8 ± 1.9 | 1.5 ± 1 | 21 ± 7.6 | 23.1 | 23.1 |
Barcelona | 52/27 | 78.8 | 12.2 ± 2.5 | 1.5 ± 2.1 | 20.8 ± 7.6 | 28.8 | 5.8 |
British Columbia | 13/16 | 86.7 | 11.1 ± 3.5 | 3.3 ± 2.7 | 14 ± 6 | 33.3 | 0 |
Calgary | 19/18 | 0 | NA | NA | 23.1 ± 4.7 | NA | NA |
Chiba | 20/6 | 40 | 11.9 ± 2.4 | 2.1 ± 1.8 | 27 ± 6.2 | 10 | 0 |
Oxford | 13/18 | 63.6 | 11.7 ± 3 | 4.7 ± 3.2 | 20 ± 7.3 | 31.8 | 22.7 |
Yale | 22/23 | 52.2 | NA | NA | 26.9 ± 4.5 | 43.5 | 39.1 |
Zurich | 22/23 | 57.1 | 11.1 ± 2.4 | 4.7 ± 2.3 | 16.1 ± 10.1 | 42.9 | 0 |
